Article Information
History
- February 9, 2022.
Article Versions
- You are currently viewing Version 1 of this article (February 9, 2022 - 21:48).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sophia Tan, BA1,
- Hailey Park1,
- Isabel Rodríguez-Barraquer, MD PhD1,2,
- George W. Rutherford, MD3,
- Kirsten Bibbins-Domingo, MD PhD2,3,
- Robert Schechter, MD MSc4 and
- Nathan C. Lo, MD PhD1,2,*
- 1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA
- 2Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
- 3Department of Epidemiology and Biostatistics and Medicine, University of California, San Francisco, San Francisco, CA, USA
- 4Immunization Branch, California Department of Public Health, Richmond, CA, USA
- ↵*Correspondence:
Nathan C. Lo, MD PhD, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA 94110, Nathan.Lo{at}ucsf.edu